Perrigo Company (PRGO) Stock Forecast & Price Target

Compare

682 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PRGO Analyst Ratings

Moderate Buy

2 Buy

1 Hold

0 Sell

Based on 3 analysts giving stock ratings to

Perrigo

Company

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PRGO Stock 12 Month Forecast

Average Price Target

$31.00

▲(46.71% Upside)

Based on 3 Wall Street analysts offering 12 month price targets for Perrigo Company in the last 3 months. The average price target is $31.00 with a high forecast of $35.00 and a low forecast of $27.00. The average price target represents a 46.71% change from the last price of $21.13.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"22":"$22","29":"$29","36":"$36","25.5":"$25.5","32.5":"$32.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$31.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$27.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[22,25.5,29,32.5,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.49,24.375384615384615,25.26076923076923,26.146153846153844,27.03153846153846,27.916923076923077,28.802307692307693,29.68769230769231,30.573076923076922,31.45846153846154,32.34384615384616,33.22923076923077,34.114615384615384,{"y":35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.49,24.067692307692305,24.645384615384614,25.22307692307692,25.80076923076923,26.378461538461536,26.956153846153846,27.533846153846152,28.111538461538462,28.689230769230768,29.266923076923078,29.844615384615384,30.42230769230769,{"y":31,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.49,23.759999999999998,24.029999999999998,24.299999999999997,24.57,24.84,25.11,25.38,25.65,25.919999999999998,26.189999999999998,26.46,26.73,{"y":27,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.74,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.88,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.39,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.55,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.87,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.1,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.05,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.07,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.69,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.1,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.31,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.49,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$35.00

Average Price Target$31.00

Lowest Price Target$27.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Chris Schott

J.P. Morgan

$35

Buy

65.64%

Upside

Reiterated

09/16/25

J.P. Morgan Reaffirms Their Buy Rating on Perrigo Company (PRGO)We are establishing a Dec 2026 price target of $35 (vs prior Dec 2025 PT of $35)

Susan Anderson

Canaccord Genuity

―

Buy

―

Reiterated

09/08/25

Canaccord Genuity Keeps Their Buy Rating on Perrigo Company (PRGO)We believe that the OTC categories listed also generally have 1 active ingredient, making it easier for consumers to research. The current dynamics should benefit Perrigo (PRGO | Buy, $40), but we also saw a stable cohort of brand loyalists that should help self-care conglomerates such as Kenvue (KVUE | Buy, $26 PT). We also believe Edgewell (EPC | Healthcare (PBH | Buy, $100 PT) are mostly insulated from any trade-down activity as EPC already offers value vs. other brands and PBH competes in niche categories with limited PL competition. Finally, we highlight e.l.f. Beauty (ELF | the mass beauty category as a potential beneficiary from consumers looking to save, and our pricing survey shows ELF is still a value vs. peers even with the $1 price increase.

Bryce Generon

TR | OpenAI - 4o

$24→$23.5

Hold

11.22%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

Keith Devas

Jefferies

$30→$27

Hold

27.78%

Upside

Reiterated

08/07/25

Jefferies Remains a Hold on Perrigo Company (PRGO)

Korinne Wolfmeyer

Piper Sandler

$27

Hold

27.78%

Upside

Reiterated

05/05/25

Analysts Conflicted on These Healthcare Names: Acrivon Therapeutics, Inc. (NASDAQ: ACRV), Align Tech (NASDAQ: ALGN) and Perrigo Company (NYSE: PRGO)

Kristina Ruggeri

Argus Research

―

Hold

―

Downgraded

01/14/25

Perrigo downgraded to Hold from Buy at ArgusPerrigo downgraded to Hold from Buy at Argus

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Chris Schott

J.P. Morgan

$35

Buy

65.64%

Upside

Reiterated

09/16/25

J.P. Morgan Reaffirms Their Buy Rating on Perrigo Company (PRGO)We are establishing a Dec 2026 price target of $35 (vs prior Dec 2025 PT of $35)

Susan Anderson

Canaccord Genuity

―

Buy

―

Reiterated

09/08/25

Bryce Generon

TR | OpenAI - 4o

$24→$23.5

Hold

11.22%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

Keith Devas

Jefferies

$30→$27

Hold

27.78%

Upside

Reiterated

08/07/25

Jefferies Remains a Hold on Perrigo Company (PRGO)

Korinne Wolfmeyer

Piper Sandler

$27

Hold

27.78%

Upside

Reiterated

05/05/25

Analysts Conflicted on These Healthcare Names: Acrivon Therapeutics, Inc. (NASDAQ: ACRV), Align Tech (NASDAQ: ALGN) and Perrigo Company (NYSE: PRGO)

Kristina Ruggeri

Argus Research

―

Hold

―

Downgraded

01/14/25

Perrigo downgraded to Hold from Buy at ArgusPerrigo downgraded to Hold from Buy at Argus

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Perrigo Company

1 Month

xxx

Success Rate

8/18 ratings generated profit

Average Return

+0.92%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 44.44% of your transactions generating a profit, with an average return of +0.92% per trade.

3 Months

xxx

Success Rate

5/18 ratings generated profit

Average Return

-3.76%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 27.78% of your transactions generating a profit, with an average return of -3.76% per trade.

1 Year

Susan AndersonCanaccord Genuity

Success Rate

2/18 ratings generated profit

Average Return

-8.97%

reiterated a buy rating 12 days ago

Copying Susan Anderson's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -8.97% per trade.

2 Years

xxx

Success Rate

0/18 ratings generated profit

Average Return

-14.05%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -14.05% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PRGO Analyst Recommendation Trends

Rating

Apr 25

May 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PRGO has received 8 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. PRGO average Analyst price target in the past 3 months is 31.00.

Each month's total comprises the sum of three months' worth of ratings.

PRGO Financial Forecast

PRGO Earnings Forecast

Next quarter’s earnings estimate for PRGO is $0.76 with a range of $0.75 to $0.77. The previous quarter’s EPS was $0.57. PRGO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year PRGO has Outperformed its overall industry.

PRGO Sales Forecast

Next quarter’s sales forecast for PRGO is $1.10B with a range of $1.09B to $1.11B. The previous quarter’s sales results were $1.06B. PRGO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.13% of the time in the same period. In the last calendar year PRGO has Preformed in-line its overall industry.

PRGO Stock Forecast FAQ

What is PRGO’s average 12-month price target, according to analysts?

Based on analyst ratings, Perrigo Company’s 12-month average price target is 31.00.

What is PRGO’s upside potential, based on the analysts’ average price target?

Perrigo Company has 46.71% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PRGO a Buy, Sell or Hold?

Perrigo Company has a consensus rating of Moderate Buy which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.

What is Perrigo Company’s price target?

The average price target for Perrigo Company is 31.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $27.00. The average price target represents 46.71% Increase from the current price of $21.13.

What do analysts say about Perrigo Company?

Perrigo Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.

How can I buy shares of PRGO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Perrigo Company (PRGO) Stock Forecast & Price Target

PRGO Analyst Ratings

PRGO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Perrigo Company

PRGO Analyst Recommendation Trends

PRGO Financial Forecast

PRGO Earnings Forecast

PRGO Sales Forecast

PRGO Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts